Gaucher disease;MALADIE DE GAUCHER

Presse Medicale

Volumn 25, Issue 3, 1996, Pages 108-112

  Kaminsky, P ^a   Belmatoug, N ^b   Billette De Villemeur, T ^c  

^a CHU NANCY BRABOIS   (France)

^b BICHAT HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCOSIDASE; GLUCOSYLCERAMIDASE;

BONE MARROW TRANSPLANTATION; CHILD; CLINICAL FEATURE; ENZYME DEFICIENCY; GAUCHER DISEASE; GENE MUTATION; HEREDITY; HUMAN; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW;

BETA-GLUCOSIDASE; GAUCHER DISEASE; GENOTYPE; HUMANS; MUTATION; PHENOTYPE;

EID: 0030063543     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Brady RO, Kanfer JN, Shapiro D. Metabolism of glucerebroside. II. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Commun 1965 ; 18:221-5.
2. Brady RO, Barton NW, Grabowski GA. The role of neurogenetics in Gaucher disease. Arch Neurol 1993 ; 50:1212-24.
3. Grabowski GA. Gaucher disease. Enzymology, genetics, and treatment. Adv Hum Genet 1993 ; 21:377-441.
4. Barranger JA, Ginns EI. Glucosylceramide lipidoses: Gaucher disease In: The metabolic basis of inherited disease, Scriver CR, Beaudet A, Sly WDV eds. McGraw-Hill, New York 1989:1677-98.
5. Erikson A. Gaucher disease - Norbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment. Acta Paediatr Scand (Suppl.) 1986 ; 326:1-42.
6. Svennerholm I, Erikson A, Groth CG, Ringden O, Mänsson JE. Norbottian type of Gaucher disease - Clinical, biochemical and molecular biology aspects: Successful treatment with bone marrow transplantation. Dev Neurosci 1991 ; 13:345-51.
7. Belmatoug N, Billette de Villemeur T. Skeletal response to enzyme replacement therapy for type 1 Gaucher disease: A preliminary report of the French experience. Semin Hematol 1995 ; 32(suppl. 1)33-8.
8. Shiran A, Brenner B, Loor A, Talarski I. Increased risk of cancer in patients with Gaucher disease. Cancer 1993 ; 72:219-24.
9. Kolodny EH, Ullman MD, Mankin HJ, Raghavan SS, Topol J, Sullivan JL. Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients. Prog Clin Biol Res 1982 ; 95:33-65.
10. Patterson MC, Horowitz M, Abel RB et al. Isolated horizontal supranuclear palsy as a marker of severe systemic involvement in Gaucher's disease. Neurology 1993 , 43:1993-7.
11. Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics 1989 ; 4:87-96.
12. Horowitz M, Tzuri G, Eyal N et al. Prevalence of nine mutations among jewish and non-jewish Gaucher disease patients. Am J Hum Genet 1993 ; 53:921-30.
13. Beutler E, Gelbart T. Gaucher disease mutations in non-Jewish patients. Br J Haematol 1993 ; 85:401-5.
14. Sibille A, Eng CM, Kim SJ, Pastores G, Grabowski GA. Phenotype/genotype correlations in Gaucher disease type I: Clinical and therapeutic implications. Am J Hum Genet 1993 ; 52:1094-101.
15. Lewis BD, Nelson PV, Robertzon EF, Morris CP. Mutation analysis of 28 Gaucher disease patients; the Australian experience. Am J Med Genet 1994 ; 49:218-23.
16. Walley AJ, Barth ML, Ellis I, Fensom AH, Harris A. Gaucher's disease in the United Kingdom: screening non Jewish patients for the two common mutations. J Med Genet 1993 ; 30:280-3.
17. Dahl N, Lagerstrom M, Erikson A, Petersson U. Gaucher disease type III (Norbottian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Am J Hum Genet 1990 ; 47:275-8.
18. Beutler E, Nguyen NJ, Henneberger HW et al. Gaucher's disease: Gene frequencies in the Ashkenazi Jewish population. Am J Hum Genet 1993 ; 52:85-8.
19. Kawame H, Maekawa K, Eto Y Molecular screening of Japanese patients with Gaucher disease, phenotypic variability in the same genotypes. Hum Mutat 1993 ; 2:362-7.
20. Zevin S, Abrahamov A, Hadas-Halpern L et al. Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy. Q J Med 1993 ; 86:565-73.
21. Barton NW, Brady RO, Dambrosia JM et al. Replacement therapy for inherited enzyme deficiency. Macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 1991 ; 324:1464-70.
22. Fallet S, Grace ME, Sibille A et al Enzyme augmentation in moderate to life-threatening Gaucher disease. Pediatr Res 1992 ; 31:496-502.
23. Pastores GM, Sibille AR, Grabowski GA. Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months. Blood 1993 ; 82:408-16.
24. Whittington R, Goa KL. Alglucerase: A review of its therapeutic use in Gaucher's disease. Drugs 1992 ; 44:72-93
25. Barton NW, Brady RO, Dambrosia JM et al. Dose-dependent response to macrophage-targeted glucocerebrosidase in a child with Gaucher disease. J Pediatr 1992 ; 120:277-80.
26. Richards SM. Protein replacement therapy for genetic disease: immunologic considerations. Int Pediatr 1993 ; 8:17-21.
27. Figueroa ML, Rosenbloom BE, Kay AC et al. A less costly regimen of alglucerase to treat Gaucher's disease. N Engl J Med 1992 ; 327:1632-6.
28. Zimran A, Elstein D, Kannai R et al. Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment. Am J Med 1994 ; 97:3-13.
29. Brady RO, Barton NW. Enzyme replacement therapy for Gaucher disease: critical investigations beyond demonstration of clinical efficacy. Biochem Med Metab Biol 1994 ; 52:1-9.
30. Rappeport JM, Ginns EI. Bone-marrow transplantation in severe Gaucher's disease N Engl J Med 1984 ; 311:84-8.
31. Hobbs JR, Shaw PJ, Jones KH, Lindsay I, Hancock M. Beneficial effect of pre-transplant splenectomy on displacement bone marrow transplantation for Gaucher's syndrome. Lancet 1987 ; i:111-15.
32. Tsai P, Lipton JM, Sahdev I et al. Allogenic bone marrow transplantation in severe Gaucher's disease. Pediatr Res 1992 ; 31:503-7.
33. Starer F, Sargent JD, Hobbs JR. Regression of the radiological changes of Gaucher's disease following bone marrow transplantation. Br J Radiol 1987 ; 60:1137-41.
34. Starzl TE, Demetris AJ, Trucco M et al. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med 1993 ; 328:745-9.